Horizon 2020: JTI-IMI2-2015-08-SINGLE-STAGE (H2020-JTI-IMI2-2015-08-SINGLE-STAGE)
*** Please refer to the Participant Portal (Links Below) for up to date and correct information. ***
The recent outbreak of Ebola virus disease (EVD) in West Africa underscores the vulnerability of populations worldwide to pathogens such as filoviral viruses. Currently, there are no vaccines or antiviral drugs approved for prevention or treatment of filoviral infections in humans.
This Call provides an opportunity to capture emerging scientific advances and to progress those rapidly into health care interventions. Proposals may address aspects of pre-clinical development and/or Phase 1, 2, and 3 clinical developments of vaccines (in particular multivalent), treatments and diagnosis of Ebola or other filovirus infections. Manufacturing strategies, vaccine stability during transport and storage, and/or deployment of vaccines and treatments are also in scope. Proposals for the development of adaptable platforms, which in addition to filoviruses can address multiple other priority pathogens, are also eligible.
This call for proposals includes the following topics. Click on the topic to link directly to the Participant Portal.
16 March 2016 17:00:00
15 September 2016 17:00:00
16 March 2017 17:00:00
14 September 2017 17:00:00
15 March 2018 17:00:00
For full details of the calls for proposals, please click the Register button below to link directly to the Participant Portal.